sec filing
ME
NASDAQ · MEDS
TRxADE HEALTH, Inc.
Healthcare · Medical - Pharmaceuticals
$0.89
Up+$0.04 (+4.82%)
Updated Sep 11, 2026, 7:25 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 13.28M
- P/E ratio
- -6.94
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 80K
- Avg. volume
- 73.36K
Price performance
MEDS price history
1M range · 20 trading sessions · Daily adjusted prices
MEDS closed at $0.89 after 20 trading sessions, down 40.13% for the selected period.
- Last close
- $0.89
- Period change
- -40.13%
- Period low
- $0.85
- Period high
- $1.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.8799 | $0.903 | $0.8501 | $0.892 | 80K |
| Sep 9, 2026 | $0.871 | $0.95 | $0.851 | $0.851 | 148.64K |
| Sep 8, 2026 | $0.9153 | $0.9188 | $0.8526 | $0.8711 | 136.68K |
| Sep 4, 2026 | $0.975 | $1.04 | $0.915 | $0.916 | 312.92K |
| Sep 3, 2026 | $1.02 | $1.0299 | $0.951 | $0.9611 | 52.11K |
| Sep 2, 2026 | $0.9696 | $1.05 | $0.9321 | $1.03 | 128.72K |
| Sep 1, 2026 | $0.94 | $1.02 | $0.9202 | $0.99 | 138.09K |
| Aug 31, 2026 | $0.878 | $1.05 | $0.8225 | $0.963 | 7.83M |
| Aug 28, 2026 | $1.15 | $1.17 | $0.9602 | $0.9606 | 129.57K |
| Aug 27, 2026 | $1.20 | $1.28 | $1.16 | $1.17 | 284.36K |
| Aug 26, 2026 | $1.35 | $1.3678 | $1.26 | $1.335 | 2.8M |
| Aug 25, 2026 | $1.32 | $1.36 | $1.30 | $1.36 | 42.73K |
| Aug 24, 2026 | $1.38 | $1.39 | $1.30 | $1.30 | 35.95K |
| Aug 21, 2026 | $1.4318 | $1.51 | $1.36 | $1.37 | 69.61K |
| Aug 20, 2026 | $1.43 | $1.4538 | $1.31 | $1.45 | 208.33K |
| Aug 19, 2026 | $1.39 | $1.5684 | $1.34 | $1.43 | 410.62K |
| Aug 18, 2026 | $1.45 | $1.50 | $1.38 | $1.38 | 64.29K |
| Aug 17, 2026 | $1.46 | $1.66 | $1.39 | $1.49 | 325.4K |
| Aug 14, 2026 | $1.53 | $1.57 | $1.43 | $1.48 | 68.14K |
| Aug 13, 2026 | $1.36 | $1.54 | $1.2551 | $1.49 | 179.54K |
Latest MEDS news
The latest Smart Investors Daily articles mentioning MEDS.
Stock researchCompany · Forecast
Loading stock research…

